This document summarizes a medical device company that provides innovative surgical products including wound closure, hernia repair, and surgical devices. The company's mission is to ethically collaborate with medical professionals to enhance patient quality of life and improve outcomes for customers and shareholders. It focuses on improving healthcare through high performance, globalization, customer focus, and innovation. The company has a history of pioneering surgical products and becoming a leader through acquisitions, product upgrades, and collaborating with prestigious hospitals. It provides summaries of its wound closure products, product enhancements, innovations, and processes for successful conversion to new products.
1. Providing Medical Miracles Through Innovative Surgical Products Wound Closure Hernia Repair Surgical Device Bio Surgery
2. Mission “Create and deliver innovative healthcare solutions, developed in ethical collaborationwith medical professionals, which enhance the quality of life for patients and improve outcomes for our customers and our shareholders.” Foundational Pillars High Performance Organization Globalization Customer Focus Innovation
4. 2007 LEADERSHIP PHASE 1998 2001 2002 PARITY PHASE 1991 1991 Tyco Acquires Davis & Geck Merges Suture Business 1995 1970 1909 PIONEERING PHASE US Surgical enters Suture Market 1985 Founding of Davis & Geck
5. LEADERSHIP PHASE NUPACK™ PACKAGING SE NEEDLE UPGRADE CAPROSYN™ DYED CAPROSYN™ SURGIPRO™ II ENHANCED SURGIPRO™ II DERMAX™ 2005 2001 2002 2003 2006 2007 OPHTHALMIC NEEDLES INDERMIL® PROTECT●POINT™ NUCOAT™ NEEDLE LINE EXPANSION NUCOAT™ ON CV NEEDLES IMPROVED MAXON™
6. Prestigious Collaboration 6of these 14 hospitals are committed Covidien Wound Closure customers All distinguished “America’s Best Hospitals” 2010-2011 Honor Roll 1. Johns Hopkins Hospital, Baltimore Mayo Clinic, Rochester, MN Massachusetts General Hospital, Boston Cleveland Clinic Ronald Reagan UCLA Medical Center, Los Angeles 6. New York-Presbyterian University Hospital of Columbia and Cornell University of California, San Francisco Medical Center Barnes Jewish Hospital/Washington University, St. Louis Hospital of the University of Pennsylvania, Philadelphia Duke University Medical Center, Durham, N.C. 11.Brigham and Women's Hospital, Boston 12.University of Washington Medical Center, Seattle 13.UPMC - Univ of Pittsburgh Medical Center University of Michigan Hospitals and Health Centers, Ann Arbor U.S. News & World Report Best Health 2010-2011
Surgipro IIPEG additive- better knot run down, less tissue dragExtrusion process- more consistent suture, reduces “surprise” breakageResin- MaxonNeedlesSurgalloy
CaprosynOnly short-term monofilament on the marker2 week wound support, absorbs in 56 daysGreat substitute for gut (synthetic, monofilament, handling)NovafilNon absorbableElastic- accommodates edema Hydrophobic- easily removable Polybutester composition- does not frayNeedlesSurgalloy- great strength NuCoat- silicone coating that provides durability pass after pass and lowered initial penetration force Variety of Needle Tip Geometries- IndermilTopical adhesive that requires only one coatRe-capable lid; allows for multiple use on one patient
Secure. Fast. Effective.
Transition Slide (from product to conversion process)People: Reps and managerscomplete a rigorous training course, highly skilled and able to explain products and processes thoroughly and effectivelyProducts: High quality and and dependable products (mention developments and changes made to products, as was discussed earlier in presentation) Process: Propriety transition process
Three core themes-explain what each theme entailsProprietary transition process which focuses on three core themes aligned to customers:
Use this as handout.Example of a customized validation plan, emphasize that each plan is tailored to fit needs of customer